| | | | Ron Squarer Chief Executive Officer |  | R. Michael Carruthers Chief Financial Officer |  | Gary M. Clark, Ph.D. Vice President, Biostatistics & Data Management |  | Howard Holden, Ph.D. Vice President, Regulatory Affairs & Quality Assurance |  | Kevin Koch, Ph.D. President & Chief Scientific Officer |  | Patrice Lee, Ph.D. Vice President, Pharmacology & Toxicology |  | John R. Moore Vice President & General Counsel |  | Michael N. Needle, M.D. Chief Medical Officer |  | Andrew Robbins Senior Vice President, Commercial Operations |  | David L. Snitman, Ph.D. Chief Operating Officer & Vice President, Business Development |  | James D. Winkler, Ph.D. Vice President, Discovery & Translational Biology |  |
| |
| |
| | | | | |
|
|